US SEC Trading Suspension Halt Orders — May 05, 2026

Failed first 180-day compliance for $1 bid price (ended May 4, 2026), below threshold for 30 consec days, no YoY stock price recovery evident

Approved Nasdaq Capital Market transfer May 6, second 180-day period to Nov 2, but reverse split consideration signals dilution risk

Bid price below $1 for 30 consec days (notification Apr 30), 180-day compliance window to Oct 27 with no immediate trading halt

Emerging growth co eligible for second 180-day period via reverse split notification, but no assurance of meeting other Capital Market standards

Stockholders' equity below $2.5M (Dec 31, 2025 10-K), fails alt MVLS/net income standards, plan due June 13

Equity at $1.92M vs $2.5M min (Dec 31, 2025), but $1.7M cash raise via 1.51M shares at $1.1235 (105% Apr 14 close) expected May 14

Mixed sentiment from equity infusion offsetting deficiency notice, emerging growth co with 45-day plan submission to June 13

Both bid price failures post-30 days, but PLAYSTUDIOS relative outperformance via Capital Market transfer and extra time

Equity shortfalls similar (~$0.6M+ deficit), VS outperforms with premium-priced capital raise vs EVTV's no-action plan

No insider purchases or capital allocation (dividends/buybacks) in enriched data, vs typical conviction signals

Transaction valuation at 105% closing price premium signals investor interest amid compliance push

Missed initial 180-day $1 bid compliance (Nov 5, 2025 notice), 30-day sub-$1 streak, delisting if fails second period by Nov 2

30 consec days below $1 (Apr 30 notice), no compliance guarantee despite reverse split option, trading uninterrupted but halt risk

Equity < $2.5M (10-K Dec 31, 2025), no alt standards met, plan rejection risks appeal/delisting post-Oct 26

$1.92M equity vs $2.5M req (Rule 5550(b)(1)), plan due June 13, deal close delay beyond May 14 heightens shortfall

Worst relative performance—first compliance failure forces tier downgrade May 6, vs others' initial notices

QoY equity decline implied to Dec 31, 2025 levels below min, no operational metrics show recovery path

4/4 negative/mixed sentiment, no forward guidance beats or insider support, pattern of Nasdaq small-cap attrition

Must notify reverse split intent for 2nd period, failure leaves single 180-day window to Oct 27

Potential reverse split to regain $1 bid by Nov 2, historical precedents yield short-term squeezes post-announcement

Eligibility for 2nd 180-day via reverse split/Capital Market transfer if standards met ex-bid price

$1.7M cash infusion May 14 at premium pricing bolsters equity above $2.5M, mixed sentiment turnaround play

Shares sold at 105% Apr 14 close ($1.1235), signals undervaluation vs Nasdaq peers, post-close momentum

Post-plan rejection, Nasdaq Hearings Panel appeal possible, low-float name for volatility trades

May 6 Capital Market move may attract value hunters if bid stabilizes, relative to pure delist risk in others

VHUB trades uninterrupted, monitor for similar transfer approval like PLAYSTUDIOS for paired short/long

High materiality (9/10) delisting paths to OTC, portfolio short basket on Nasdaq micro-caps with sub-$1/equity fails

2/4 (50%) failed $1 min for 30 days, implying YoY stock price declines >50% in gaming/tech micro-caps, accelerates delistings

2/4 (50%) below $2.5M as of Dec 31, 2025, no net income/MVLS alts met, signals persistent QoQ balance sheet weakness

All plans due June 13, 2026 (EVTV/VS confirmed), extensions to late Oct, creates Q3 catalyst congestion for small caps

Versus sole $1.7M premium raise (1/4), others no transactions, highlights relative financing access in emerging growth cos

2/4 (PLAY/VHUB) eyeing splits for extra time, common in sub-$1 names but dilutive, avg historical +20-50% pops then fades

100% materiality 9/10, negative sentiment 75%, pattern warns of Nasdaq small-cap purge wave in 2026

Monitor listing move impact and bid price trajectory, effective May 6, 2026 [May 6]

Watch announcement/intent for 2nd compliance push to Nov 2, 2026 [By Nov 2]

Track $1 bid for 10 consec days toward Oct 27 deadline, reverse split eligibility [By Oct 27]

Submission due June 13, extension decision and appeal potential to Oct 26 [June 13]

$1.7M equity raise completion to address $0.58M shortfall, Nasdaq plan impact [May 14]

45-day submission June 13, post-raise equity check for Oct 26 extension [June 13]

No trades in enriched data, watch for buys/sells signaling conviction pre-deadlines [Ongoing Q2 2026]

QoQ updates post-Dec 31, 2025 lows, net income/MVLS alts for plan viability [June 13]